Rexahn Pharmaceuticals Inc (NYSE American:RNN)

1.74
Delayed Data
As of Feb 20
 -0.04 / -2.25%
Today’s Change
1.69
Today|||52-Week Range
7.10
-13.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization37.1K28.3K27.5K32.9K
 
 
 
 
 
 
Operating ExpensesGross Income-37.1K-28.3K-27.5K-32.9K
 
 
 
 
 
General Expenses7.9M13.2M18.2M16.4M
 
 
 
 
 
Research And Development3.3M7.0M12.1M10.1M
 
 
 
 
 
Total Operating Expenses8.0M13.3M18.3M16.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.0M-13.3M-18.3M-16.4M
 
 
 
 
 
Extraordinary Credit0.000.004.0M7.3M
 
 
 
Extraordinary Charge-1.4M-5.2M0.000.00
 
 
 
Interest Expense On Debt0.000.000.00313.1K
 
 
Other Expenses-204.2K-206.2K-211.1K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.5M-18.5M-14.4M-9.3M
 
 
 
 
 
Net Income-9.5M-18.5M-14.4M-9.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.9M17.6M18.2M21.7M
 
 
 
 
 
Shares To Calculate EPS Diluted12.9M17.6M18.2M21.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.70-$1.10-$0.80-$0.40
 
 
 
 
 
EPS Diluted-$0.70-$1.10-$0.80-$0.40